Oriented circular dichroism was used to study the alignment crown ether-modified peptides. The influence of different N-and C-functionalities was assessed using at variable peptide:lipid ratios from 1:20 to 1:200. Neither the functionalities nor the concentration had any major effect on the orientation. The alignment of the 21-mer peptides was also examined with lipid membranes of different bilayer thickness. The use of synchrotron radiation as light source allowed the study of peptide:lipid molar ratios from 1:20 to 1:1000. For all conditions studied, the peptides were found to be predominantly incorporated as a transmembrane helix into the membrane, especially at low peptide concentration, but started to aggregate on the membrane surface at higher peptide:lipid ratios. The structural information on the preferred trans-bilayer alignment of the crown ether functional groups explains their ion conductivity and is useful for the further development of membrane-active nanochemotherapeutics.
INTRODUCTION
Peptides have tremendous potential as therapeutic agents, 1 and peptide-based therapies are used regularly in clinics to treat a variety of diseases. For example, they have been used as pro-apoptotic nongated nanopores. 2 Some amphipathic peptides can form selfassembled structures, which are able to span cell membranes. 3 Such nanopores may act as toxins by enabling the free passage of ions, as this destroys the usual ionic gradients of a cell and leads to its death. For instance, the natural antibiotics gramicidin A, 4 alamethicin, 5 melittin, 6 and magainin 7 are membrane-active peptides that are well known as pore-forming toxins. Gramicidin A and alamethicin, both of which have a predominantly hydrophobic surface when folded, are generally inserted in a transmembrane alignment. 4, 8 Amphiphilic helices like magainin, on the other hand, are known to reside favorably on the membrane surface and tend to insert only transiently to self-assemble as pores. 9, 10 These kind of membrane interactions of natural and biomimetic peptides open the door to the possibility to fight bacteria as well as cancer cells, and is of great interest for nanochemotherapy.
Another efficient way to create functional nanopore would be to use a helical membrane spanning peptide as molecular scaffold to orient synthetic ionophores forming artificial ion channels. Towards such monomeric peptide nanopore, we have designed a family of 21-residue crown ether modified peptides exemplified by 1, 2, and 3 in Figure 1A as potential nanochemotherapeutics. Previous studies showed that they exist mainly in a helical conformation, in which the crown ether side chains can align as a stack (Figures 1B and 1C) to form monomeric functional ion channels. 11, 12 Such nanostructures have been shown to be efficient toxins against breast cancer and leukemia cancer cells.
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FIGURE 1 21-Residue crown ether modified peptides used in this study (A) their schematic representation in an a-helical conformation (B) and their helical wheel projection (C).
Circular dichroism (CD) has several advantages over other biophysical techniques to examine the structural basis that drives the interaction of crown peptides 1-3 with bilayer membranes: there is no need to label any part of the helix, only a few micrograms of peptide sample is required to get a good signal, and the relatively high rate of scanning allows fast screening of many conditions in a short period of time. Oriented CD (OCD) on macroscopically aligned samples is ideally suited to determine the membrane orientation of a-helical peptides, especially whether they orient parallel (I-state) or perpendicular (Sstate) to the bilayer normal, and at the same time the secondary structure of the peptide can be monitored (Figure 2 ). [14] [15] [16] With regard to the crown ether peptides, it has been shown that they tend to fold as a-helices and interact with membranes. 17 However, the polyethylene glycol (PEG)-based crown ethers are intrinsically amphiphilic and known to be soluble both in polar and unpolar solvents. Therefore, it is unknown whether these functional groups prefer to face the aqueous layer on the membrane surface (i.e., with the peptide in an S-state), or whether they would rather immerse into the hydrophobic bilayer interior (in an I-state). Determination of the membrane interactions of the peptide backbone will thus help us to understand the mechanism of ion conduction by crown ether modified peptides. We have demonstrated that crown peptide 1-3 assumes an Istate that allows the passage of ions; 12 however, the experimental conditions were very different than those where ion channel activity was observed. 18 Hence, this model remains to be proven at experimentally relevant conditions, especially at lower concentrations. FIGURE 2 (A) Peptide orientations in lipid bilayers for the surface aligned S-state, the inserted I-state, and the tilted T-state; and (B) the corresponding idealized calculated OCD spectra.
Here, we report the effects of peptide concentration, of the N-and C-functionalities, and of the bilayer thickness, on the interaction of crown ether peptides with model membranes, studied by OCD and synchrotron radiation-based oriented circular dichroism (SR-OCD).
MATERIALS AND METHODS
Chemicals 1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-dimyristoleoyl-snglycero-3-phosphocholine (DMoPC), 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), and 1,2-dierucoyl-sn-glycero-3-phosphocholine (DErPC) were purchased from Avanti Polar Lipids and used without further purification. Peptides 1, 2, and 3 were synthesized as described previously 13 and purified by high performance liquid chromatography on a Phenomenex (JupiterVR , 10 µm, C4, 300 Å, 250 Х 21.2 mm) semipreparative column using a solvent gradient (90% H 2 O/5% acetonitrile/5% isopropanol to 50% acetonitrile/50% isopropanol in 50 min). Peptides were then characterized by mass spectrometry.
CD Spectroscopy
Weighed amounts of the DMPC lipid powder and lyophilized peptide 1 were dissolved in chloroform/methanol (50:50 v/v) to get stock solutions. Aliquots of these stock solutions were mixed in a glass vial and thoroughly vortexed to achieve a codissolved mixture with a peptideto-lipid (P:L) ratio of 1:100. The organic solvents were removed under a gentle stream of nitrogen gas, followed by 3-4 h vacuum pumping to remove the solvent residuals from the mixture. The peptide/lipid film that had formed in the vial was dispersed by adding 300 µL phosphate buffer solution (10 mM, pH 7.0) and strong vortexing. Multilamellar vesicles were obtained by putting the solution through 10 freezethaw cycles as follows: immersion in liquid nitrogen for one minute, immersion in water at 40°C for 2 min and then vortexed for one more minute. Finally, small unilamellar vesicles were obtained by sonicating for 16 min in a strong, ultrasonic bath (UTR 200, Hielscher, Germany) thermostated at 30°C. At this point, the sample had lost its turbidity and was placed in a 1 mm SUPRASIL quartz glass cuvette (Hellma, Germany). The concentration of DMPC in the final sample was kept at 1 mg/mL. Three scans were collected and averaged at 30°C using a Jasco-815 spectropolarimeter at a scan rate of 10 nm/min from 260 to 180 nm. After subtracting the baseline spectrum of a corresponding DMPC vesicle dispersion without peptide, the data were smoothed by using a SavitzkyGolay algorithm contained in the J-815 software and converted to mean residue ellipticity.
OCD Spectroscopy
Aliquots of a 0.6 mg/mL stock solution of peptides in CHCl 3 /MeOH (50:50 v/v) were mixed with aliquots of a 5 mg/mL stock solution of lipids to achieve P:L ratios of 1:20, 1:100, and 1:200. Each mixture was vortexed and aliquots of 36.2, 61.0, and 50.5 mL were deposited on quartz glass plate (Suprasil QS, Hellma Optik, Jena, Germany), respectively, in a 6 mm radius round spot. For the 1:20 mixture, the amount of lipid on the plate was kept at 50 µg, and for the two other mixtures at 200 µg. In all cases, the amount of peptide was kept below 30 µg. Two reference plates were made with 50 and 200 µg of pure lipids on a plate. The deposited peptide/lipid solutions on the plates were allowed to dry in air and afterwards under vacuum for 3 h. Finally, they were hydrated overnight above the lipid phase transition temperature at 30°C under 97% relative humidity (K 2 SO 4 saturated solution atmosphere) in a custom-built OCD cell, which has been described in detail earlier. 16 Measurements were performed on a Jasco J-810 spectropolarimeter. Three sets of scans running at 10 nm/min were ran at 30°C in a 97% relative humidity atmosphere from 260 to 180 nm for each of the eight 45° rotation positions from 0° to 315°.
For quality control, to ensure that there was no strong inhomogeneity in the samples, after every measurement the linear dichroism (LD) was recorded to check that the maximum LD was below 0.003 dOD, and a photo of the plates supporting the macroscopically oriented bilayers was taken. Results were repeated three times with different stock solutions to obtain triplicates. To make sure the stock solutions were of similar concentration each time, their absorbance at 282 nm was measured and the concentration was verified by Beer-Lambert law.
SR-OCD Spectroscopy
The sample preparation was similar to the one described above for conventional OCD spectroscopy. In addition, two more solutions of P:L 5 1:500 and 1:1000 were prepared. The amount of lipids on the plate for these ratios was kept at 500 µg. Measurements were carried out on the UVCD-12 beamline at the ANKA synchrotron facility at KIT. 19 Because of to the 1000 higher photon flux of this setup compared with a bench-top CD spectropolarimeter, one scan running at 15 nm/min at each rotation angle is enough to obtain high quality data. For the eight angles, data were collected from 270 to 175 nm at 30°C under 97% relative humidity. The rest of the procedure is identical to that described above.
Data Processing
After collection of the data, the spectra obtained at 8 rotational angles for references and samples were averaged. This compensates spectral artefacts such as linear dichroism of the sample and birefringence of the optical elements of the instrument. Subsequently, the appropriate background reference was subtracted from the sample spectra for all peptide:lipid ratios. After this step, normalization was performed by scaling the magnitude of the ellipticity for all samples to the same value at the wavelength that corresponds to the n-π* electronic transition found in the isotropic CD spectrum obtained previously for the vesicles.
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RESULTS AND DISCUSSION
Conformational Studies
Before studying the orientational behavior of peptide 1, we investigated its conformation in sonicated DMPC vesicles using circular dichroism (CD) (Figure 3 ). Secondary structure analysis using the spectrum of the reconstituted peptide shows that the peptide is mostly helical (68%). It has only small contributions of unordered structures (12%), β-strands (11%), and β-turns (9%), according to the mean values obtained by three different algorithms: SELCON-3, CONTIN-LL, and CDSSTR. [22] [23] [24] [25] The characteristic CD bands of a helix can be clearly identified, which are slightly red-shifted for this synthetic peptide (one maximum at 194 nm and two minima at 211 nm and 224 nm) as compared to the band positions found for natural peptides. These values confirm that the nanostructure has folded in its predicted functional conformation as an α-helix with the side chains aligned in a way that the crown ethers can form a channel. Because of the free tumbling of the vesicles in the aqueous suspension inside the cuvette, this CD spectrum is isotropic, and we refer to it as the "isotropic peptide spectrum." Knowing the positions of the intrinsic bands, it is now possible to normalize the data in a way that we can follow the π-π* electronic band, in this case the 211 nm band, and interpret its negative or positive intensity in aligned samples for the orientational studies. 
Orientational Studies
We used OCD to study the orientation of peptide 1 in DMPC bilayers, and we also evaluated the influence of chemical modifications at its N-and C-termini. As seen in Figure  4 , all three crown ether peptides are helical in the oriented samples and have CD bands in the same positions as observed in the isotropic vesicle spectrum, namely at 194 and 224 nm. However, the band at 211 nm has vanished for all peptides and at all peptide:lipid ratios. This characteristic feature can be attributed to peptides adopting a membrane inserted I-state 14, 26 ( Figure 4) . The line shapes of 1, 2, and 3 closely overlap. This indicates that even if 3 is more hydrophobic than 1 at both termini, it behaves in the same way in the presence of DMPC bilayers. This is most probably due to the high hydrophobicity of the leucine-rich backbone reducing the influence of end groups. Examining the different peptide:lipid molar ratios, we see for each peptide a reduction in the spectral intensity at 194 nm at high concentration, which is a typical sign of absorption flattening. 27 Comparing the three peptides at the same peptide:lipid ratio at short wavelengths (180-200 nm), we find that 2 has a greater intensity than 3, and 3 has a greater intensity than 1. This phenomenon is most likely due to the absorption features of the N-terminal functionalities, since their UV extinction coefficients follow the same trend; the carbonyl of 2 and 3 is the strongest chromophore and the free terminus of 1 is the weakest.
On the basis of these results, we continued to use peptide 1 for further SR-OCD investigation of its membrane orientation in lipid bilayers of different thickness. We incorporated the peptide in sonicated vesicles made of thin DMoPC bilayers (di-C14:1), of medium DOPC (di-C18:1), and of thick bilayers of DErPC (di-C22:1). These three unsaturated lipids were selected, because they are in the liquid-crystalline phase at an ambient experimental temperature of 30°C, given their lower phase transition temperatures compared to the saturated variants. If we had wanted to examine the saturated variants in the fluid phase at correspondingly higher temperatures, the deposited short chain lipids would flow down off the quartz glass plate that is mounted vertically in the OCD cell at temperatures >40°C. Unfortunately, unsaturated lipids absorb much light in the far UV region of the CD spectrum 28 and give rise to considerable artifacts on a conventional spectropolarimeter, unless the sample volume is dramatically reduced. For such sample it would not be possible then to record a spectrum of quality due to an insufficient signal-to-noise ratio. However, by using synchrotron radiation as an intense light source 29 it is possible to radically reduce the concentration of chromophores, and to work with very low P:L ratios. 30 As in the conventional OCD spectra above (Figure 4 ), peptide 1 always shows two bands at 194 and 224 nm in Figure 5 , indicating an α-helical structure throughout. At the lowest concentration of 1:1000, it exists exclusively in an I-state, whatever the thickness of the bilayer. The positive ellipticity at 211 nm is characteristic of a transmembrane helix. 31 As the peptide concentration rises, 1 appears to shift from an I-state towards a more tilted T-state. This new state may be explained in three different ways. First, the peptide can become progressively tilted in the bilayer by an increasing angle, leading to a genuine Tstate. Second, it could be depicted as a rapid timeaveraged interconversion, where the Istate is in dynamic equilibrium with an S-state. Finally, it could be portrayed by the summation of signals originating from static peptide units locked in the two different Iand S-orientations. The latter scenario is the most probable, because the new state appears as the peptide concentration rises. It would be unlikely for a T-state to become more tilted as we increase the peptide:lipid ratio. Also, a time-averaged interconversion of 1 would not be significantly influenced by changes of the concentration as observed in this case. Thus, a plausible interpretation implies that a major part of the peptide adopts an I-state, while increasing concentration leads to the expulsion of excess peptide from the bilayer, which then resides on the surface in an S-state. Alternatively, this excess fraction of peptides could also be present as nonoriented aggregates that may no longer be accommodated by the lipids, given that an S-state lineshape cannot be easily distinguished from an isotropic helical spectrum. In either case, the sum of the predominant I-state and the new S-state or aggregated state would result in the observed increase of the 211 nm band intensity. According to the results obtained, we conclude that 1 is completely inserted at the lowest concentration studied. Adding more peptide to the system leads to the appearance of a negative 211 nm band, as clearly observed in the DMoPC system illustrated in Figure 5A . This could be due to a saturation of the bilayers by transmembrane peptides, which leaves no choice for the newly added peptides but to lie on the bilayer surface or to aggregate even outside of the membrane. The same behavior is also noted with DOPC and DErPC bilayers: the 211 nm signal increases until a critical ratio of 1:200 and 1:500 is reached, respectively. At higher concentrations, the signal changes its lineshape and begins to fade, most likely due to absorption flattening. The fact that the sum of the I-state and the new state results in a weaker signal is in full support of our hypothesis on the formation of helical aggregates. In fact, when the concentration of hydrophobic peptides, such as 1, is relatively high on the surface of a bilayer, they tend to aggregate through hydrophobic interactions. 32 Inspection of Figure 5 shows that increasing the membrane thickness has the same effect as increasing the peptide concentration. Compared to DMoPC, the relative fraction of aggregated peptide increases in DOPC and even more so in DErPC. To estimate the hydrophobic length of the peptide, we consider the CD-determined helix content of 1 (68%) to obtain a helix length of around 21 Å. 33 This value fits well to the hydrophobic thickness of DMoPC, which is also 21 Å. 34 Some mismatch seems to occur in thicker bilayers, leading to a less favorable membrane insertion of 1 in DOPC and DErPC. 35 As described by Ren et al. 36 for the highly hydrophobic peptide poly Leu, when the length of the helix is thinner than the width of the lipid bilayer, the S-state is preferred, while a helix length that fits well the width of the bilayer favors the I-state. This is also part of what we observed with the difference that the thickness of the bilayer is not the only factor influencing the incorporation of crown ether peptides in lipid bilayers. Indeed, we observed that when the length of the helix is shorter than the thickness of the bilayer, the peptide remains in a transmembrane orientation even at low concentration. The same behavior has been thoroughly studied by Ding et al. with the antimicrobial peptide LL-37 which also adopted the I-state at physiologically-relevant concentrations. 37 Then, as peptide concentration increases, LL-37 switches from the I-to the S-state, just as if the newly added peptides would expelled ouf of the bilayer the inserted ones. Thus, both the concentration and the length of the transmembrane domain play crucial roles on whether the peptide adopts an S-or an I-state.
Compared to the well characterized structural behavior of amphiphilic peptides, which tend to prefer a surface-bound state at low concentration, the observed membrane insertion of the crown ether peptide 1 may appear quite unusual. 9, 10, 19, 38, 39 However, considering the highly hydrophobic character of the leucine-based peptide framework together with the promiscuous solubility of the PEG-derived crown ethers, it is not surprising that peptide 1 acts more like a hydrophobic helix than an amphiphilic one. Such behavior corroborates earlier results obtained by polarized ATR and SS-NMR, where the peptide at high concentrations (P:L ratios between 1:10 and 1:60) was shown to be in a two-state equilibrium: aggregated on the surface and inserted in bilayers. 12, 40 The I-state at low P:L ratios also supports results that have shown ion transport at low peptide concentration in vesicle assays using fluorescence, implying that channel 1 is mainly inserted in a transmembrane state under such conditions.
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CONCLUSIONS
Using OCD, we found that crown ether-modified peptide 1 and its analogs insert favorably as a transmembrane helix into various phosphatidylcholine bilayers, especially at low P:L ratios such as 1:1000. A modest effect on the peptide insertion is also attributed to the thickness of the bilayer membrane and the associated hydrophobic mismatch. These results support the model that as the peptide concentration increases, the orientation of 1 shifts from a fully inserted transmembrane I-state to a mixture of I-and S-states, and eventually it forms aggregates on the surface. Our design strategy has thus been met with success, as a small quantity of crown peptide 1 can be incorporated into lipid membranes and will readily fold as a transmembrane helix, which is the active conformation to form functional ion channels.
On the basis of our understanding of the membrane behavior of 1 gained at clinically relevant concentrations, we are currently exploring its outstanding potential to form channels to develop improved nanochemotherapeutics. We found SROCD a particularly useful method for studying peptidemembrane interactions under biologically relevant conditions, as it only requires peptides in the nanomolar range. This is the first time that membrane-active peptides have been studied with this highly sensitive technique at peptide:lipid ratios as low as 1:1000.
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